Press release
Aneurysmal Subarachnoid Hemorrhage Drugs Market to Witness Robust Expansion by 2029
Aneurysmal subarachnoid hemorrhage drugs market is anticipated to grow at a significant CAGR during the forecast period. Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke. It is caused by bleeding in the space surrounding the brain. It mostly occurs due to bursts and leaks of a weak area in a blood vessel on the surface of the brain due to which blood builds up around the brain and inside the skull increasing pressure on the brain. The major factor driving the demand for aneurysmal subarachnoid hemorrhage drugs is the increasing geriatric population and the high prevalence of populations suffering from hypertension across the globe.According to the Center for Disease Control and Prevention, nearly half of adults or 47%, or 116 million have hypertension which is defined as a systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg or are taking medication for hypertension in the US. Additionally, about 1 in 4 adults (24%) with hypertension have their condition under control and about half of the adults or 45% or 37 million with uncontrolled hypertension have a blood pressure of 140/90 mmHg or higher in the US. Furthermore, about 34 million adults are recommended to take medication and about two out of three of this group or 19 million have a blood pressure of 140/90 mmHg or higher. Hence, the increasing prevalence of hypertension is creating a risk for aneurysmal subarachnoid hemorrhage which is driving the demand for these drugs.
Some major players in the market include Johnson & Johnson Services, Inc., Pfizer Inc., and Mylan N.V., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2020, Idorsia Ltd. announced positive top-line results of the Japanese registration program which investigated clazosentan in adult Japanese patients post aneurysmal subarachnoid hemorrhage (aSAH).
To Request a Sample of our Report on Aneurysmal Subarachnoid Hemorrhage Drugs Market: https://www.omrglobal.com/request-sample/aneurysmal-subarachnoid-hemorrhage-drugs-market
Market Coverage
The market number available for - 2021-2029
Base year- 2021
Forecast period- 2023-2029
Segment Covered-
By Type
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Johnson & Johnson Services, Inc., Pfizer Inc., and Mylan N.V., among others.
Aneurysmal Subarachnoid Hemorrhage Drugs Market Report by Segment
By Type
Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic agents/diuretics
Other
A full Report of Aneurysmal Subarachnoid Hemorrhage Drugs Market is Available @ https://www.omrglobal.com/industry-reports/aneurysmal-subarachnoid-hemorrhage-drugs-market
Aneurysmal Subarachnoid Hemorrhage Drugs Market Report by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East & Africa
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ec%84%b1%ec%9e%a5-%ea%b0%80%ec%86%8d%ed%99%94%eb%a5%bc-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-acidophilus-probiotic-%ec%8b%9c%ec%9e%a5/288429/
https://monblogapple.com/2023/01/27/le-marche-des-systemes-de-protection-active-connaitra-une-croissance-fulgurante-dici-2029/
https://citytoday-hildesheim.de/index.php/2023/01/27/der-luftfahrttelekommunikationsmarkt-wird-bis-2029-eine-wachstumsbeschleunigung-erleben/
https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%aa%d9%88%d9%82%d8%b9-%d8%a3%d9%86-%d9%8a%d8%b2%d8%af%d8%a7%d8%af-%d8%b3%d9%88%d9%82-%d8%a7%d8%b3%d8%aa%d8%ae%d8%b1%d8%a7%d8%ac-%d8%a7%d9%84%d8%ac%d8%b0%d8%b1-%d9%85/
https://revistaeconomiasocial.com/2023/01/27/el-mercado-de-la-fecula-de-patata-sera-testigo-de-un-crecimiento-asombroso-para-2029/
https://www.diario-ya.com/regionales/%e9%9b%99%e7%9b%b8%e6%83%85%e6%84%9f%e9%9a%9c%e7%a4%99%e8%97%a5%e7%89%a9%e5%b8%82%e5%a0%b4%e5%88%b0-2029-%e5%b9%b4%e5%b0%87%e5%bf%ab%e9%80%9f%e5%a2%9e%e9%95%b7/348282/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aneurysmal Subarachnoid Hemorrhage Drugs Market to Witness Robust Expansion by 2029 here
News-ID: 2902690 • Views: …
More Releases from Orion Market Research

Middle Earth Orbit (MEO) Satellite Market Set to Witness Significant Growth by 2 …
the global Medium Earth Orbit (MEO) satellite market was valued at approximately USD 8.24 billion in 2024 and is projected to reach USD 14.78 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.02% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/middle-earth-orbit-meo-satellite-market
Middle Earth Orbit (MEO) Satellite Market Overview:
The Medium Earth Orbit (MEO) satellite market is a rapidly evolving segment of the global space…

Microwave Ablation Market Size Future Scope, Demands and Projected Industry Grow …
In 2024, the global microwave ablation devices market is estimated to be valued at approximately USD 450 million. Looking ahead, the market is projected to reach around USD 1.2 billion by 2033, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2033 .
Microwave Ablation Market Overview
The global microwave ablation market is experiencing significant growth, driven by the increasing prevalence of cancer and the rising demand for…

Media, Sera and Reagents Market Development, Industry Trends, Demand and Growth …
In 2024, the global media, sera, and reagents market is estimated to be valued at approximately USD 8.12 billion. Looking ahead, the market is projected to reach around USD 9.11 billion by 2033, growing at a compound annual growth rate (CAGR) of 3.9% from 2025 to 2033.
Media, Sera and Reagents Market Overview
The global media, sera, and reagents market is experiencing steady growth, driven by advancements in biotechnology, pharmaceuticals, and…

Lithium-Ion Battery Anode Market By Application Analysis, Regional Outlook, Comp …
The global lithium-ion battery anode market is projected to reach approximately USD 138.45 billion by 2033, growing from an estimated USD 14.32 billion in 2024 at a compound annual growth rate (CAGR) of 30.9% from 2025 to 2033.
Lithium-Ion Battery Anode Market Overview
The lithium-ion battery anode market is experiencing significant growth, driven by the increasing adoption of electric vehicles (EVs), the expansion of renewable energy storage solutions, and the proliferation of…
More Releases for Aneurysmal
Aneurysmal Subarachnoid Hemorrhage Drugs Market Size & Growth Analysis Report, 2 …
The global aneurysmal subarachnoid hemorrhage drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke. It is caused by bleeding in the space surrounding the brain. It mostly occurs due to bursts and leaks of a weak area in a blood vessel on the surface of the brain due to which blood builds up around…
Aneurysmal Subarachnoid Hemorrhage Market Real Time Analysis & Forecast 2017 – …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot
According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the…
Aneurysmal Subarachnoid Hemorrhage Market Prospective Growth 2025 - Arbor Pharma …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot
According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the…
Aneurysmal Subarachnoid Hemorrhage Market Preventing challenges complications 20 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot
According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the…
Top Factors Driving the Global Aneurysmal Subarachnoid Hemorrhage Drugs Market
HTF MI recently introduced Global Aneurysmal Subarachnoid Hemorrhage Drugs Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. At present, the market is developing its presence and some of the key players from the complete study are Arbor Pharmaceuticals Inc. (US), Edge Therapeutics, Inc. (US), Johnson & Johnson (Actelion Pharmaceuticals Ltd.) (US), Mylan N.V. (US), Orexo AB (Sweden), Pfizer…
Aneurysmal Subarachnoid Hemorrhage Market witness lethargic growth 2025
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot
According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the…